Dr. Daniel Vitt

Portrait Dr. Daniel Vitt
Chief Executive Officer and Director

Dr. Daniel Vitt

Daniel Vitt, Ph.D., joined Immunic in January 2017, and subsequent to the company’s reverse takeover transaction with Vital Therapies in 2019, has served as Chief Executive Officer, President and Director of Immunic, Inc. Previously, he was Chief Scientific Officer and Chief Development Officer of 4SC AG, a publicly traded company based in Germany that he co-founded in 1997. While there, he successfully grew the company from the research stage into an advanced therapeutic development company with several clinical-stage product candidates in the pipeline.

Dr. Vitt studied chemistry in Siegen and Würzburg, Germany, and graduated from the University of Würzburg, where he focused on quantum-chemical calculations of organic reactions. He received his Ph.D. from the Institute of Organic Chemistry at the University of Würzburg, where he focused on molecular design of small molecule therapeutics.

Dr. Vitt is currently a member of the advisory board of the venture capital fund “Wachstumsfond Bayern 2,” managed by Bayern Kapital GmbH. In 2018, he also co-founded Brauhaus Germering GmbH, a local German specialty brewery.

Back to Team Members